Legal & General Group PLC Cerus Corp Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Cerus Corp stock. As of the latest transaction made, Legal & General Group PLC holds 19,832 shares of CERS stock, worth $34,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares

19,832

Previous 19,394 2.26%

Holding current value

$34,706

Previous $36,000 5.56%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.62 - $2.04 $709 - $893	438 Added 2.26%	19,832 $34,000
Q1 2024 May 14, 2024	SELL	$1.66 - $2.42 $13,756 - $20,054	-8,287 Reduced 29.94%	19,394 $36,000
Q4 2023 Feb 15, 2024	SELL	$1.25 - $2.35 $165,620 - $311,365	-132,496 Reduced 82.72%	27,681 $59,000
Q3 2023 Nov 14, 2023	SELL	$1.5 - $3.07 $795,816 - $1.63 Million	-530,544 Reduced 76.81%	160,177 $259,000
Q2 2023 Aug 14, 2023	BUY	$1.79 - $2.9 $399,375 - $647,033	223,115 Added 47.71%	690,721 $1.7 Million
Q1 2023 May 15, 2023	BUY	$2.65 - $3.81 $312,230 - $448,905	117,823 Added 33.68%	467,606 $1.39 Million
Q4 2022 Feb 14, 2023	SELL	$3.38 - $4.22 $29,237 - $36,503	-8,650 Reduced 2.41%	349,783 $1.28 Million
Q3 2022 Nov 14, 2022	BUY	$3.43 - $5.83 $103,157 - $175,337	30,075 Added 9.16%	358,433 $1.29 Million
Q2 2022 Aug 22, 2022	BUY	$4.41 - $5.69 $130,522 - $168,406	29,597 Added 9.91%	328,358 $1.74 Million
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $70,408 - $102,319	-14,638 Reduced 4.67%	298,761 $1.64 Million
Q4 2021 Feb 14, 2022	SELL	$5.97 - $7.93 $310,266 - $412,130	-51,971 Reduced 14.22%	313,399 $2.13 Million
Q3 2021 Nov 15, 2021	BUY	$4.79 - $6.68 $18,810 - $26,232	3,927 Added 1.09%	365,370 $2.23 Million
Q2 2021 Aug 12, 2021	BUY	$5.35 - $6.35 $195,189 - $231,673	36,484 Added 11.23%	361,443 $2.14 Million
Q1 2021 May 17, 2021	BUY	$5.68 - $7.87 $1.03 Million - $1.43 Million	181,534 Added 126.57%	324,959 $1.95 Million
Q4 2020 Feb 12, 2021	BUY	$5.25 - $8.56 $192,827 - $314,400	36,729 Added 34.42%	143,425 $993,000
Q3 2020 Nov 13, 2020	BUY	$5.78 - $7.47 $101,976 - $131,793	17,643 Added 19.81%	106,696 $668,000
Q2 2020 Aug 14, 2020	BUY	$4.5 - $7.02 $137,088 - $213,857	30,464 Added 52.0%	89,053 $588,000
Q1 2020 May 14, 2020	BUY	$2.87 - $5.49 $31,983 - $61,180	11,144 Added 23.49%	58,589 $266,000
Q4 2019 Feb 13, 2020	BUY	$3.84 - $4.86 $24,076 - $30,472	6,270 Added 15.23%	47,445 $199,000
Q3 2019 Nov 13, 2019	BUY	$4.86 - $6.05 $49,100 - $61,123	10,103 Added 32.51%	41,175 $211,000
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $16,578 - $24,261	3,676 Added 13.42%	31,072 $174,000
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $6,439 - $8,548	1,248 Added 4.77%	27,396 $171,000
Q4 2018 Feb 15, 2019	BUY	$4.89 - $7.16 $20,645 - $30,229	4,222 Added 19.26%	26,148 $133,000
Q2 2018 Aug 10, 2018	SELL	$5.19 - $7.25 $14,018 - $19,582	-2,701 Reduced 10.97%	21,926 $146,000
Q1 2018 May 17, 2018	SELL	$3.56 - $5.74 $11,687 - $18,844	-3,283 Reduced 11.76%	24,627 $135,000
Q4 2017 Feb 13, 2018	BUY	$2.76 - $3.95 $77,031 - $110,244	27,910	27,910 $95,000

Others Institutions Holding CERS

# of Institutions

149

Shares Held

147M

Call Options Held

191K

Put Options Held

43.9K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $310M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Cerus Corp Transaction History